期刊文献+

尿微量白蛋白阴性的超重肥胖2型糖尿病患者估算的肾小球滤过率下降的相关危险因素分析 被引量:10

Estimated glomerular filtration rate and associated risk factors in overweight or obese patients with type 2 diabetes and normal urine microalbumin level
原文传递
导出
摘要 2011年8月至2012年3月,从广东省内60家医院收集门诊或住院已确诊2型糖尿病且合并体重指数≥24kg/m^2的患者5241例,其中随机尿微量白蛋白〈30mg/L的患者共2631例。根据估算的肾小球滤过率(eGFR)水平将其分为正常组及下降组,应用Binary logistic回归方法对eGFR的相关危险因素进行分析。结果显示,年龄、尿酸、尿素氮、冠心病史、高血压病史、糖尿病家族史、高尿酸血症与eGFR下降呈独立正相关(P〈0.05或P〈0.01),HbA1c达标、定期监测血糖、规律运动与eGFR下降呈独立负相关(均P〈0.01)。提示超重或肥胖的2型糖尿病患者应联合使用尿微量白蛋白及eGFR全面评估。肾功能情况,并严格控制血糖、血压及血尿酸水平以减少糖尿病肾病的发生风险。 From August 2011 to March 2012, 5 241 type 2 diabetic patients with body mass index ≥ 24 kg/m2 were enrolled from 60 hospitals in Guangdong Province. According to estimated glomerular filtration rate (eGFR) , a total of 2 631 subjects with normal urine microalbumin level ( 〈30 mg/L) were divided into normal eGRF group and decreased eGRF group. Binary logistic regression was used to analyze the associations between eGFR and its related risk factors. The results showed that age, blood uric acid, blood urea nitrogen, history of hypertension and coronary heart disease, family history of diabetes, and hyperurieemia were positively related to lowering of eGFR ( P〈 0.05 or P〈0.01 ). HbA1c〈7% , regular glucose monitoring, and regular physical activity were negatively related to eGFR decrease ( all P 〈 0. 01 ). These results suggest that urine microalbumin and eGFR should be applied to overweight or obese patients with type 2 diabetes in order to screen diabetic nephropathy. Furthermore, intensive control of blood glucose, uric acid, and blood pressure is beneficial to lowering the risk of diabetic nephropathy.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2014年第1期43-46,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 超重 肥胖 糖尿病 2型 估算的肾小球滤过率 尿微量白蛋白 Overweight Obesity Diabetes mellitus, type 2 Estimated glomerular filtration rate Urine microalbumin
  • 相关文献

参考文献25

  • 1Agrawal L,Azad N,Emanuele NV. Observation on renal outcomes in the Veterans Affairs Diabetes Trial[J].{H}DIABETES CARE,2011.2090-2094.
  • 2吴楠,胡仁明.肾小球滤过率估算公式在糖尿病患者中的应用[J].复旦学报(医学版),2011,38(3):275-280. 被引量:3
  • 3Maclsaac R J,Tsalamandris C,Panagiotopoulos S. Nonalbuminuric renal insufficiency in type 2 diabetes[J].{H}DIABETES CARE,2004.195-200.
  • 4MacIsaac RJ,Panagiotopoulos S,McNeil KJ. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease[J].{H}DIABETES CARE,2006.1560-1566.
  • 5Rocco MV,Berns JS. KDOQI Clinical Practice Guideline for Diabetes and CKD:2012 Update[J].{H}American Journal of Kidney Disease,2012.850-886.
  • 6National kidney Fundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].{H}American Journal of Kidney Disease,2002,(2 Suppl 1):S1-S266.
  • 7Pugliese G,Solini A,Bonora E. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes[J].{H}ATHEROSCLEROSIS,2011.194-199.
  • 8Wall BM,Hardison RM,Molitch ME. High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease:the BARI 2D baseline data[J].{H}AMERICAN Journal OF THE MEDICAL SCIENCES,2010.401-410.
  • 9Retnakaran R,Cull CA,Thorne KI. Risk factors for renal dysfunction in type 2 diabetes:U.K.Prospective Diabetes Study 74[J].{H}DIABETES,2006.1832-1839.
  • 10卢筱华,冯烈,蒋亚斌,周幼芬.不伴白蛋白尿的2型糖尿病患者肾小球滤过率危险因素分析[J].南方医科大学学报,2010,30(11):2502-2504. 被引量:2

二级参考文献42

  • 1Kramer H, Molitch ME. Screening for kidney disease in adults with diabetesIJl. Diabetes Care, 2005, 28(7): 1813-6.
  • 2Macicaac R J, Panagiotopoulos S, McNeil KJ, et al. Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease [J]? Diabetes Care, 2006, 29 (7): 1560-6.
  • 3Macicaac RJ, Tsalamandris C, Panagiotopoulos S, et al. Nonal- buminuric renal insufficiency in type 2 diabetesrJl. Diabetes Care, 2004, 27(1): 195-200.
  • 4Retnakaran R, Cull CA, Thome K1, et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74 [J]. Diabetes, 2006, 55(6): 1832-9.
  • 5Castellani S, Ungar A, Cantini C, et al. Excessive vasoconstriction after stress by the aging kidney: inadequate prostaglandin modulation of increased endothelin activity [J].J Lab Clin Med, 1998, 132(3): 186-94.
  • 6Chantrel F, Moulin B, Hannedouche T. Blood pressure, diabetes and diabetic nephropathy[J]. Diabetes Metab, 2000, 26(Suppl 4): 37-44.
  • 7Ogbera AO, Azenabor AO. Hyperuricaemia and the metabolic syndrome in type 2 DM[J]. Diabetol Metab Syndr, 2010, 2: 24.
  • 8Fukui M, Tanaka M, Shiraishi E, et al. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus [J]. Metabolism, 2008, 57(5): 625-9.
  • 9Rigalleau V,Lasseur C,Raffaitin C.The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects[J].Nephrol Dial Transplant,2007,22(3):813-818.
  • 10Fontsere N,Bonal J,Salinas I.Is the new Mayo Clinic Quadratic equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?[J].Diabetes Care,2008,31(12):2 265-2 267.

共引文献3

同被引文献101

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部